E-cadherin is over-expressed in well-differentiated ovarian cancers, while under-expressed E-cadherin is detected in ascites, advanced cancer, and metastases, and is predictive of poor OS [106,107,108]. Here, CDH1 is linked to ovarian carcinoma.